VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $650 | +33.7% | 150,399 | +103.7% | 0.01% | +50.0% |
| Q2 2023 | $486 | -99.5% | 73,822 | +631.0% | 0.00% | +300.0% |
| Q3 2022 | $100,000 | -93.4% | 10,099 | -92.7% | 0.00% | -94.4% |
| Q2 2022 | $1,506,000 | +82.1% | 138,176 | +88.9% | 0.02% | +80.0% |
| Q1 2022 | $827,000 | +17.6% | 73,131 | +63.2% | 0.01% | +42.9% |
| Q4 2021 | $703,000 | +92.1% | 44,815 | +163.1% | 0.01% | +75.0% |
| Q2 2021 | $366,000 | -55.2% | 17,034 | -68.7% | 0.00% | -66.7% |
| Q1 2021 | $817,000 | +383.4% | 54,402 | +322.1% | 0.01% | +500.0% |
| Q4 2020 | $169,000 | -61.9% | 12,887 | -52.2% | 0.00% | -75.0% |
| Q4 2019 | $443,000 | – | 26,968 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |